Vsee Health, Inc.
VSEECIK 1864531HealthcareFiscal year ends Dec 31
Reports and events: 134 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0121:29 ET | S-1 | Registration statement | 0001185185-26-004518 |
| 2026-09-3020:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-004440 |
| 2026-09-2320:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-26-004244 |
| 2026-09-0920:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-003896 |
| 2026-08-3120:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001185185-26-003768 |
| 2026-08-2620:10 ET | 8-K | 5.07 Shareholder vote results | 0001185185-26-003729 |
| 2026-08-1420:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001185185-26-003549 |
| 2026-08-0421:20 ET | 8-K | 3.01 Delisting notice | 0001185185-26-003262 |
| 2026-07-3120:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-003211 |
| 2026-07-2420:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001185185-26-003124 |
| 2026-07-2012:30 ET | DEF 14A | Proxy statementPeriod 2026-08-25 | 0001185185-26-003024 |
| 2026-07-1020:31 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001185185-26-002887 |
| 2026-07-0720:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002823 |
| 2026-06-2620:33 ET | 8-K | 2.04 Item not in the standard list | 0001185185-26-002686 |
| 2026-06-1120:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002468 |
| 2026-06-1120:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002467 |
| 2026-06-0520:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-26-002359 |
| 2026-05-1519:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001185185-26-001883 |
| 2026-03-3121:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001185185-26-001202 |
| 2026-03-0321:05 ET | 8-K | 5.07 Shareholder vote results | 0001185185-26-000736 |
| 2026-02-1922:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-26-000625 |
| 2026-02-0515:15 ET | DEF 14A | Proxy statementPeriod 2026-03-02 | 0001185185-26-000413 |
| 2026-01-0221:00 ET | 8-K | 5.07 Shareholder vote results | 0001185185-26-000009 |
| 2025-12-2921:33 ET | S-1 | Registration statement | 0001185185-25-002184 |
| 2025-12-1811:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-25-002102 |
| 2025-12-1221:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-002039 |
| 2025-12-1122:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-25-002025 |
| 2025-12-1120:17 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-002019 |
| 2025-12-0421:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-118335 |
| 2025-11-2821:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-001884 |
| 2025-11-2621:40 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001870 |
| 2025-11-2421:10 ET | DEF 14A | Proxy statementPeriod 2025-12-15 | 0001185185-25-001847 |
| 2025-11-2022:14 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-06-30 | 0001185185-25-001818 |
| 2025-11-1721:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001777 |
| 2025-11-1712:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-25-001763 |
| 2025-11-1421:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001185185-25-001744 |
| 2025-10-2911:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-25-001563 |
| 2025-10-2820:16 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001185185-25-001551 |
| 2025-10-2212:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-25-001518 |
| 2025-10-2021:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-25-001496 |
| 2025-10-1521:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001185185-25-001450 |
| 2025-10-1521:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001185185-25-001448 |
| 2025-10-1412:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001185185-25-001434 |
| 2025-10-1001:34 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-25-001417 |
| 2025-09-2900:19 ET | 8-K | 3.01 Delisting notice | 0001185185-25-001289 |
| 2025-09-0521:20 ET | 8-K | 3.01 Delisting notice | 0001185185-25-001135 |
| 2025-08-2910:17 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001558370-25-011815 |
| 2025-08-2821:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-011813 |
| 2025-08-2821:08 ET | 8-K | 4.02 Non-reliance on financial statements | 0001104659-25-084843 |
| 2025-08-2221:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-081950 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.